Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Molecular Cancer Therapeutics
|
February 3, 2007
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect
Yuval Sheffer, Oded Leon, Jehonathan H Pinthus, et al.
Journal of Hepatology
|
January 24, 2004
Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes
Yulia Gnainsky, Gadi Spira, Melia Paizi, et al.
British Journal of Haematology
|
April 27, 2012
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents
Merav Leiba, Jana Jakubikova, Steffen Klippel, et al.
Cancer Biology & Therapy
|
July 21, 2015
Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model
Einav Mayzlish-Gati, Dana Laufer, Christopher F Grivas, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Molecular Cancer Therapeutics
|
February 3, 2007
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect
Yuval Sheffer, Oded Leon, Jehonathan H Pinthus, et al.
Journal of Hepatology
|
January 24, 2004
Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes
Yulia Gnainsky, Gadi Spira, Melia Paizi, et al.
British Journal of Haematology
|
April 27, 2012
Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents
Merav Leiba, Jana Jakubikova, Steffen Klippel, et al.
Cancer Biology & Therapy
|
July 21, 2015
Strigolactone analogs act as new anti-cancer agents in inhibition of breast cancer in xenograft model
Einav Mayzlish-Gati, Dana Laufer, Christopher F Grivas, et al.
Page
of 6